共 93 条
[1]
Stupp R(2009)Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 459-466
[2]
Hegi ME(2005)Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 987-996
[3]
Mason WP(2014)Factors associated with a higher rate of distant failure after primary treatment for glioblastoma J Neuro-Oncol 116 169-175
[4]
Stupp R(1990)Response criteria for phase II studies of supratentorial malignant glioma J Clin Oncol 8 1277-1280
[5]
Mason WP(2000)New guidelines to evaluate the response to treatment in solid tumours JNCI J Natl Cancer Inst 92 205-216
[6]
van den Bent MJ(2013)Response assessment criteria for glioblastoma: practical adaptation and implementation in clinical trials of antiangiogenic therapy Curr Neurol Neurosci Rep 13 347-1972
[7]
Tejada S(2010)Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group J Clin Oncol 28 1963-203
[8]
Díez-Valle R(2015)Evaluation of RANO response criteria compared to clinician evaluation in WHO grade III anaplastic astrocytoma: implications for clinical trial reporting and patterns of failure J Neuro-Oncol 122 197-930
[9]
Aldave G(2012)Reevaluating the imaging definition of tumour progression: perfusion MRI quantifies recurrent glioblastoma tumour fraction, pseudoprogression, and radiation necrosis to predict survival Neuro-Oncology 14 919-986
[10]
Macdonald DR(2001)The RECIST (Response Evaluation Criteria in Solid Tumours) criteria: implications for diagnostic radiologists Br J Radiol 74 983-885